LCM
CNTA

Landscape Capital Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Landscape Capital Management’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-90,240
Closed -$1.02M – 740
2024
Q1 		$1.02M Buy
+90,240
New +$855K 0.09% 286

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Landscape Capital Management's CNTA Position: Q2 2024 in Review

Landscape Capital Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2024, closing a stake of 90,240 shares — an estimated $1.02M sold.

Landscape Capital Management first reported a position in CNTA in Q1 2024 and held it in 1 quarter. The position peaked at $1.02M in Q1 2024. 80 funds tracked by Wall St. Rank hold CNTA as of Q2 2024.

  • Landscape Capital Management reported no remaining Centessa Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Landscape Capital Management sold 90,240 Centessa Pharmaceuticals shares in Q2 2024, an estimated $1.02M.
  • Landscape Capital Management first reported a position in Centessa Pharmaceuticals in Q1 2024 and held it in 1 quarter.
  • Landscape Capital Management's Centessa Pharmaceuticals position peaked at $1.02M in Q1 2024.
  • 80 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2024.

Based on Landscape Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.